Innovative berry-based skin spray targets hospital-acquired bacteria

FHS
August 28, 2024
11:34 am

VTT has developed a skin spray, based on nanocellulose and antimicrobial compounds from wild berries, which can be used to treat wounds and eliminate hospital-acquired bacteria such as MRSA before surgery.

FDA spells out new expedited withdrawal procedures for accelerated approvals

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 6, 2024

Supreme Court Declines Biden’s Appeal in Texas Emergency Abortion Case

A court order that says hospitals cannot federally be required to provide pregnancy terminations when they violate a Texas abortion ban will stay for now,

October 9, 2024

Cannabist Q3 Was Flat Sequentially

The Cannabist Company Reports Third Quarter 2023 Results NEW YORK–(BUSINESS WIRE)–The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.